News
DGAP-News: Adler Group S.A.: achieves transformational milestone
DGAP-News: Adler Group S.A.: achieves transformational milestone
DGAP-Adhoc: Subsidiary sells a c.7% stake in Brack Capital Properties N.V and grants tender commitment for all its remaining shares in BCP until 30 September 2022
DGAP-Adhoc: Subsidiary sells a c.7% stake in Brack Capital Properties N.V and grants tender commitment for all its remaining shares in BCP until 30 September 2022
DGAP-News: CPI PROPERTY GROUP - Capital Increase Completed
DGAP-News: CPI PROPERTY GROUP - Capital Increase Completed
EQS-News: u-blox AG: New u-blox AWS IoT ExpressLink Modules Offer Out-of-the-Box Secure Connectivity to the AWS Cloud
EQS-News: u-blox AG: New u-blox AWS IoT ExpressLink Modules Offer Out-of-the-Box Secure Connectivity to the AWS Cloud
DGAP-News: CPI PROPERTY GROUP - Financial Results for the Third Quarter of 2021
DGAP-News: CPI PROPERTY GROUP - Financial Results for the Third Quarter of 2021
DGAP-Adhoc: SynBiotic SE: Majority takeover of hemp industry pioneer Daniel Kruse's group of companies as part of a capital increase in kind
DGAP-Adhoc: SynBiotic SE: Majority takeover of hemp industry pioneer Daniel Kruse's group of companies as part of a capital increase in kind
DGAP-News: Aves One increases sales and operating result in the first nine months of 2021
DGAP-News: Aves One increases sales and operating result in the first nine months of 2021
DGAP-News: Endor AG publishes nine-month figures 2021 and expects dynamic development in Q4
DGAP-News: Endor AG publishes nine-month figures 2021 and expects dynamic development in Q4
DGAP-News: Brockhaus Technologies AG: Brockhaus Technologies successfully closes the acquisition of Bikeleasing
DGAP-News: Brockhaus Technologies AG: Brockhaus Technologies successfully closes the acquisition of Bikeleasing
DGAP-News: Abivax's phase 1/2 clinical study results of ABX196 in liver cancer show good tolerability and promising signals of clinical benefit and were selected for presentation at the ASCO GI Cancers Symposium
DGAP-News: Abivax's phase 1/2 clinical study results of ABX196 in liver cancer show good tolerability and promising signals of clinical benefit and were selected for presentation at the ASCO GI Cancers Symposium
BILENDI: Bilendi announces the completion of the the acquisition of the respondi group
BILENDI: Bilendi announces the completion of the the acquisition of the respondi group
Custodian REIT plc : Total Voting Rights
Custodian REIT plc : Total Voting Rights
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Superdry plc: Total Voting Rights
Superdry plc: Total Voting Rights
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: Playtech plc
Form 8.3 - The Vanguard Group, Inc.: Playtech plc
DGAP-News: Voltabox Management and New Anchor Shareholders in Close Talks about Future Strategy
DGAP-News: Voltabox Management and New Anchor Shareholders in Close Talks about Future Strategy
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Equiniti Group plc
Form 8.3 - The Vanguard Group, Inc.: Equiniti Group plc
DGAP-News: Media and Games Invest: Official rollout of advertising targeting solution ATOM: strong performance of 28% higher click-through-rates and app 15% better monetization compared to campaigns without IDFA
DGAP-News: Media and Games Invest: Official rollout of advertising targeting solution ATOM: strong performance of 28% higher click-through-rates and app 15% better monetization compared to campaigns without IDFA
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
DGAP-Adhoc: VERBIO Vereinigte BioEnergie AG: VERBIO increases EBITDA earnings forecast for the financial year 2021/2022 from initially planned EUR 150 million to EUR 230 million.
DGAP-Adhoc: VERBIO Vereinigte BioEnergie AG: VERBIO increases EBITDA earnings forecast for the financial year 2021/2022 from initially planned EUR 150 million to EUR 230 million.